news
Interview with Danaë Delbeke, CEO
Gent, Belgium – The Belgian business journal De Tijd featured last weekend an interview with Danaë Delbeke, CEO of our company Indigo Diabetes. Read Danäe Delbeke's interview with De Tijd. The article is in the Dutch language. Source:...
Indigo Diabetes concludes a €38 million round of financing
July 27, 2020 - Ghent, Belgium Invisible sensor for people with diabetes aims at measuring multiple metabolites BELGIUM - Ghent, July 27, 2020 – Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today...
“Lekker koken met diabetes”
The Diabetes Liga will launch on April 4th its unique cookbook "Lekker koken met diabetes". It is the ideal cookbook to introduce a healthy and tasty diet to people with diabetes. This cookbook is supported by Indigo, Medtronic, Novo Nordisk, Canderel and Pure Via....
ATTD 2020 – Video
Watch here the full oral presentation of Dr. David Stocker on continuous real-time ketone sensing in subcutaneous tissue with combined glucose/ketone sensor: proof-of-concept in pig model [video width="960" height="540"...
Indigo at ATTD 2020 – Madrid
Join us at ATTD in Madrid on Saturday February 22nd for the oral presentation session 10 starting 10h30 in the La Paz conference room. We are honoured to share with you the results of our pre-clinical research on continuous real-time ketone sensing in subcutaneous...
Indigo at J.P. Morgan 2020 Healthcare Conference
Indigo will be present during the J.P. Morgan 2020 Healthcare conference on January 13-16 in San Francisco, USA. If you are interested to talk to us, we will be delighted to meet you. Please contact us danae.delbeke@indigomed.com (+32 475 41 21 32)
Indigo receives ISO 13485 certification
Ghent, Belgium [November 22, 2019] – Indigo Diabetes NV, a medical device company creating next-gen sensors for diabetes healthcare, today announced it has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and...
Clinical Study Action-1 kicked-off: T1D in action for Ketones and Lactate
Indigo is pleased to announce that the first patient has now been enrolled into ‘Action-1”, the company’s prospective, non-randomized, interventional, multi-center data collection study. The study collects venous blood samples in male T1D patients to evaluate the...